Journal of Cancer · 2019 · 49 citations · 51 references
MedicineCancer BiologyOncologyMolecular OncologyNeoplasiaTumor MicroenvironmentAngiogenesisAngiogenesis In CancerCancer BiomarkersLung CancerMalignant NeoplasmsSquamous Cell CarcinomaAngiogenesis In NeoplasmsAngiogenic BiomarkersHif-1 Alpha RegulationHypoxic MicroenvironmentLung AdenocarcinomaTissue MicroarraysTumor Microenvironment HypoxiaVascular Endothelial Growth Factor
Background: Vascular endothelial growth factor A (VEGFA) and angiopoietin 2 (ANGPT2) are key mediators in angiogenesis. The expression and clinical significance of VEGFA and ANGPT2 have been investigated in lung cancer, but the results are controversial. The specific roles of VEGFA and ANGPT2 in adenocarcinoma (ADC) and squamous cell carcinoma (SQC) are still not fully understood. To characterize it, we conducted the current study.
51
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Comprehensive genomic characterization of squamous cell lung cancers
K. Jin Kim, Bing Li, Jane Winer et al. · Nature · 1993 · 3.6K citations
Medicine, Cancer Biology, Oncology +14